Phoenix Wealth Advisors Makes New $859,000 Investment in ARK Genomic Revolution ETF $ARKG

Phoenix Wealth Advisors purchased a new stake in shares of ARK Genomic Revolution ETF (BATS:ARKG) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 15,845 shares of the company’s stock, valued at approximately $859,000.

Several other large investors have also made changes to their positions in the company. NewEdge Advisors LLC raised its holdings in ARK Genomic Revolution ETF by 102.6% during the 1st quarter. NewEdge Advisors LLC now owns 24,092 shares of the company’s stock worth $637,000 after purchasing an additional 12,202 shares during the last quarter. Nwam LLC lifted its position in ARK Genomic Revolution ETF by 55.3% during the 2nd quarter. Nwam LLC now owns 31,704 shares of the company’s stock valued at $1,333,000 after purchasing an additional 11,294 shares during the period. Wealth Management Partners LLC boosted its stake in shares of ARK Genomic Revolution ETF by 78.1% in the 3rd quarter. Wealth Management Partners LLC now owns 27,319 shares of the company’s stock valued at $1,481,000 after purchasing an additional 11,979 shares during the last quarter. Gimbal Financial bought a new position in shares of ARK Genomic Revolution ETF in the 3rd quarter valued at about $6,478,000. Finally, Group One Trading LLC boosted its stake in shares of ARK Genomic Revolution ETF by 168.3% in the 1st quarter. Group One Trading LLC now owns 45,861 shares of the company’s stock valued at $1,212,000 after purchasing an additional 28,765 shares during the last quarter.

ARK Genomic Revolution ETF Stock Up 1.9%

Shares of BATS:ARKG traded up $0.83 during trading on Friday, hitting $45.45. 4,007,262 shares of the company’s stock were exchanged, compared to its average volume of 3,542,198. ARK Genomic Revolution ETF has a 1-year low of $24.60 and a 1-year high of $58.83. The firm has a 50-day moving average price of $49.73 and a two-hundred day moving average price of $37.76.

ARK Genomic Revolution ETF Company Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.